Search Within

Myeloma

Formats
  1. Meeting Abstract (557)
  2. Journal Article (368)
  3. Review (37)
  4. Research Letter (21)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (7)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (1016)
  2. Department of Medicine (1016)
  3. Hematologic Malignancies, Division of (1016)
  4. Hematologic Malignancies Research (669)
  5. Survivorship Research (374)
  6. Sloan Kettering Institute Postdocs (306)

More Groups

People
  1. Alexander Lesokhin (381)
  2. Hani Hassoun (339)
  3. Carl Landgren (336)
  4. Sham Mailankody (297)
  5. Malin Hultcrantz (274)
  6. Heather Landau (249)

More People

Years
  1. 2025 (28)
  2. 2024 (82)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (317)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (86)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (24)

More Publications

Publishers
  1. American Society of Hematology (340)
  2. Elsevier Inc. (160)
  3. American Society of Clinical Oncology (88)
  4. Nature Publishing Group (87)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (1016)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rational targets in systemic AL amyloidosis
    Meeting Abstract

    Bal, S.; Dogan, A.; Hassoun, H.; Mailankody, S.; Giralt, S. A.; Landau, H. J.
    Blood (2021)

    Fulltext@MSK | Save
  • Melflufén más dexametasona en pacientes con mieloma múltiple recidivante/resistente (MMRR) con exposición/resistencia previa a agentes alquilantes: Análisis conjunto de los estudios O-12-M1 y HORIZON
    Meeting Abstract

    Rodriguez-Otero, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Bladé, J.; Cavo, M.; Leleu, X.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
    Journal Article

    Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Functional impact of genomic complexity on the transcriptome of multiple myeloma
    Journal Article

    Ziccheddu, B.; Da Vià, M. C.; Lionetti, M.; Maeda, A.; Morlupi, S.; Dugo, M.; Todoerti, K.; Oliva, S.; D'Agostino, M.; Corradini, P.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and COVID-19: A population-based cohort study
    Journal Article

    Rognvaldsson, S.; Eythorsson, E.; Thorsteinsdottir, S.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdóttir, I.; Olafsson, I.; Runolfsdottir, H. L.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Melflufen plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) exposed/refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies
    Meeting Abstract

    Rodríguez-Otero, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Leleu, X.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM)
    Meeting Abstract

    Bahlis, N. J.; Raje, N. S.; Costello, C.; Dholaria, B. R.; Solh, M. M.; Levy, M. Y.; Tomasson, M. H.; Dube, H.; Liu, F.; Liao, K. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Anakinra (AKR) prophylaxis (ppx) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) receiving orvacabtagene autoleucel (orva-cel)
    Meeting Abstract

    Costa, L. J.; Mailankody, S.; Shaughnessy, P.; Hari, P.; Kaufman, J. L.; Larson, S. M.; Dingli, D.; Lee, K.; Conte, K.; DeVries, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Safety and PK/PD of ALLO-647, an anti-CD52 antibody, with fludarabine (Flu)/cyclophosphamide (Cy) for lymphodepletion in the setting of allogeneic CAR-T cell therapy
    Meeting Abstract

    Tees, M. T.; Neelapu, S. S.; Hari, P.; Mailankody, S.; Miklos, D. B.; Locke, F. L.; Nath, R.; Prashad, S. L.; Zhou, X.; Demirhan, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients
    Meeting Abstract

    Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save